Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy.
Eur J Gastroenterol Hepatol
; 35(1): 45-51, 2023 01 01.
Article
en En
| MEDLINE
| ID: mdl-36468568
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Enfermedad de Crohn
Límite:
Humans
Idioma:
En
Revista:
Eur J Gastroenterol Hepatol
Asunto de la revista:
GASTROENTEROLOGIA
Año:
2023
Tipo del documento:
Article